How We Help
Strategic Launch Report and Evaluate Forecast can help commercial teams produce more accurate forecasts of launch activity, even in new indications and those with a lot of pipeline and/or competitive activity and limited payer coverage.
Reveal
Highlight potential obstacles from new drug launch policies.
Correlate
Correlate analogs’ policy uptake with sales volumes to get a complete picture and set realistic launch expectations.
Increase Efficiency
Increase rebate processing team efficiency.
Reduce Leakage
Reduce rebate leakage and protect millions of dollars from leaving your organization due to incorrect formulary and medical benefit positioning.
Improve Reach
Conduct more comprehensive contract evaluation.
Identify
Identify scenarios when agents with more restrictive or slow policy uptake still experienced sales uptake or vice versa.
Understand
Through color commentary from Evaluate and MMIT syndicated reports, understand the reasoning behind what payer did vs. what physicians did.
Minimize Errors
Minimize data inaccuracies and human-made errors.
